Petrus Trust Company, Lta Bio Rad Laboratories, Inc. Transaction History

Petrus Trust Company, Lta

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$268.26 - $339.48 $434,581 - $549,957	1,620 New	1,620 $442,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $39,597 - $53,660	147 Added 17.5%	987 $318,000
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $585,968 - $707,059	-1,673 Reduced 66.57%	840 $301,000
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $903,398 - $1.22 Million	2,513 New	2,513 $952,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $209,267 - $271,325	595 Added 92.97%	1,235 $519,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $264,057 - $360,486	640 New	640 $267,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.